Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:115  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 

    Article Cited by others


Treatment of visceral leishmaniasis

Moore E M, Lockwood D N

Year : 2010| Volume: 2| Issue : 2 | Page no: 151-158

   This article has been cited by
1 Is leishmaniasis an “unusual suspect” of infection in allogeneic transplantation?
A. Komitopoulou,T. Tzenou,J. Baltadakis,J. Apostolidis,D. Karakasis,N. Harhalakis
Transplant Infectious Disease. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
2 Immunity to visceral leishmaniasis: implications for immunotherapy
Forough Khadem,Jude E Uzonna
Future Microbiology. 2014; 9(7): 901
[Pubmed]  [Google Scholar] [DOI]
3 Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs derived from Withania somnifera and Asparagus racemosus
S. Kaur,K. Chauhan,H. Sachdeva
Journal of Medical Microbiology. 2014; 63(Pt_10): 1328
[Pubmed]  [Google Scholar] [DOI]
4 Drug delivery: lessons to be learnt fromLeishmaniastudies
CD Shaw,KC Carter
Nanomedicine. 2014; 9(10): 1531
[Pubmed]  [Google Scholar] [DOI]
5 Design, Synthesis, ADME Characterization and Antileishmanial Evaluation of Novel Substituted Quinoline Analogs
Vadiraj S. Gopinath,Rao Mukkavilli,Rahul Shivahare,Preeti Vishwakarma,Sweta Ghose,Ashok Pradhan,Mohan Hindupur,Koushik Das Sarma,Suman Gupta,Sunil K. Puri,Delphine Launay,Denis Martin
Bioorganic & Medicinal Chemistry Letters. 2014;
[Pubmed]  [Google Scholar] [DOI]
6 A new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies
Muzamil Yaqub Want,Mohammad Islamuddin,Garima Chauhan,Anjan Kumar Dasgupta,Asoke Prasun Chattopadhyay,Farhat Afrin
Journal of Colloid and Interface Science. 2014;
[Pubmed]  [Google Scholar] [DOI]
7 Chemotherapy of leishmaniasis part X: Synthesis and bioevaluation of novel terpenyl heterocycles
Avinash Tiwari,Santosh Kumar,S.N. Suryawanshi,Monika Mittal,Preeti Vishwakarma,Suman Gupta
Bioorganic & Medicinal Chemistry Letters. 2013; 23(1): 248
[Pubmed]  [Google Scholar] [DOI]
8 Lipid synthesis in protozoan parasites: A comparison between kinetoplastids and apicomplexans
Srinivasan Ramakrishnan,Mauro Serricchio,Boris Striepen,Peter Bütikofer
Progress in Lipid Research. 2013; 52(4): 488
[Pubmed]  [Google Scholar] [DOI]
9 Análisis de la utilización de anfotericina B liposomal
María González Martínez,Carolina Mariño Martínez,Gema Baldominos Utrilla,María Nélida Fernández Martínez
Revista Iberoamericana de Micología. 2013;
[Pubmed]  [Google Scholar] [DOI]
10 Chemotherapy of leishmaniasis. Part XI: Synthesis and bioevaluation of novel isoxazole containing heteroretinoid and its amide derivatives
S.N. Suryawanshi,Avinash Tiwari,Naveen Chandra,Naveen Ramesh,Suman Gupta
Bioorganic & Medicinal Chemistry Letters. 2012; 22(21): 6559
[Pubmed]  [Google Scholar] [DOI]
11 Kala Azar – letaler Verlauf einer viszeralen Leishmaniose
C. Posch,J. Walochnik,A. Gschnait,H. Feichtinger,K. Rappersberger
Der Hautarzt. 2012; 63(12): 947
[Pubmed]  [Google Scholar] [DOI]
12 Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection
S.A. Campbell,J. Alawa,B. Doro,F.L. Henriquez,C.W. Roberts,A. Nok,C.B.I. Alawa,M. Alsaadi,A.B. Mullen,K.C. Carter
Vaccine. 2012; 30(7): 1357
[Pubmed]  [Google Scholar] [DOI]
13 Autophagy in Trypanosomatids
Ana Brennand,Eva Rico,Paul A. M. Michels
Cells. 2012; 1(4): 346
[Pubmed]  [Google Scholar] [DOI]
14 New parasite inhibitors encompassing novel conformationally-locked 5'-acyl sulfamoyl adenosines
Shailesh S. Dixit,Ram Shankar Upadhayaya,Jyoti Chattopadhyaya
Organic & Biomolecular Chemistry. 2012; 10(30): 6121
[Pubmed]  [Google Scholar] [DOI]
15 Development of Luciferase Expressing Leishmania donovani Axenic Amastigotes as Primary Model for In Vitro Screening of Antileishmanial Compounds
Richard H. Ravinder,Richard H. Bhaskar,Sonali Gangwar,Neena Goyal
Current Microbiology. 2012; 65(6): 696
[Pubmed]  [Google Scholar] [DOI]
16 An unusual case of anaemia in an octogenarian
L. McCusker,J. Platt
Age and Ageing. 2012; 41(5): 696
[Pubmed]  [Google Scholar] [DOI]
17 Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium
Igor Grekov,Milena Svobodová,Eva Nohýnková,Marie Lipoldová
Journal of Microbiological Methods. 2011; 87(3): 273
[Pubmed]  [Google Scholar] [DOI]
18 Polyamine homoeostasis as a drug target in pathogenic protozoa: peculiarities and possibilities
Lyn-Marie Birkholtz,Marni Williams,Jandeli Niemand,Abraham I. Louw,Lo Persson,Olle Heby
Biochemical Journal. 2011; 438(2): 229
[Pubmed]  [Google Scholar] [DOI]
19 Molecular factors governing inhibition of arylimidamides against Leishmania: Conservative computational modeling to improve chemotherapies
Catharine J. Collar,Xiaohua Zhu,Karl Werbovetz,David W. Boykin,W. David Wilson
Bioorganic & Medicinal Chemistry. 2011; 19(15): 4552
[Pubmed]  [Google Scholar] [DOI]
20 Overview of treatment options for invasive fungal infections
Melanie W. Pound,Mary L. Townsend,Vincent Dimondi,Dustin Wilson,Richard H. Drew
Medical Mycology. 2011; : 1
[Pubmed]  [Google Scholar] [DOI]
21 Leishmaniasis
E. M. Moore,D. N. Lockwood
Clinical Medicine. 2011; 11(5): 492
[Pubmed]  [Google Scholar] [DOI]


Read this article
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008